Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum

Xanthelasma palpebrarum (XP) is the most common type of cutaneous xanthoma, characterized by yellowish cutaneous plaques commonly located near the medial canthus of the eyelid. Although dyslipidemia significantly contributes to its development, inflammation is also believed to be another element in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Beyoglu Eye Journal 2024, Vol.9 (1), p.33-37
Hauptverfasser: Ergun, Sule Berk, Kurt, Busra
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 37
container_issue 1
container_start_page 33
container_title Beyoglu Eye Journal
container_volume 9
creator Ergun, Sule Berk
Kurt, Busra
description Xanthelasma palpebrarum (XP) is the most common type of cutaneous xanthoma, characterized by yellowish cutaneous plaques commonly located near the medial canthus of the eyelid. Although dyslipidemia significantly contributes to its development, inflammation is also believed to be another element in the pathogenesis, especially in normolipidemic patients. Recently, cell counts derived from complete blood counts have been identified as indicators of systemic inflammatory conditions and have also been under discussion concerning their relevance to ocular diseases. This study aimed to assess inflammation indices derived from complete blood cell counts (CBC) in XP patients with normal lipid levels. Patients who had been referred to the oculoplasty department with the diagnosis of XP between January 2020 and January 2023 and age-matched control subjects were retrospectively reviewed. Patients who had abnormal lipid profiles and systemic diseases such as diabetes mellitus, hypertension, malignancy, cardiovascular diseases, systemic infections, and inflammatory diseases were not included in the study. CBC parameters were analyzed and compared between the groups. The study comprised 27 normolipidemic patients with XP and 27 age-matched healthy individuals as the control group. There were no statistically significant differences between the two groups in terms of age (p=0.143). The mean hemoglobin, neutrophil, monocyte, lymphocyte, platelet, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, and aggregate index of systemic inflammation values were higher in the patient group, but the differences were not statistically significant (p>0.05). The mean red cell distribution width and platelet-to-lymphocyte ratio appeared to be lower in the patient group compared to the control group; however, no significant differences were observed between the two groups (p=0.272, p=0.387, respectively). This study might offer insights into the pathogenesis of XP, yet numerous questions remain unanswered, awaiting further investigation in future studies.
doi_str_mv 10.14744/bej.2024.48802
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10944854</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A789048832</galeid><sourcerecordid>A789048832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3912-6b883f6892f9539e3e79e1d8eb6da9e469aaac57fe1895c08f80c7bcc4b525323</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEolXpmRuKxIVLtv6M7RPabgtdaSU4gMTNcpxJ14tjL3ZSxL_H7PYDkA-2Zp55NTN-q-o1RgvMBGMXHewWBBG2YFIi8qw6JVyKBlHFnpc346rBQoiT6jznHUKIcEyw4i-rEyo5YqrFp1W3iuPewwT1pY-xr1fgfb2Kc5iaK0juDvp6HQZvxtFMLob60sXRpO-Qcu1C_bkEIUy5_ummbf3NhGkL3uTRlIzfQ5dMmsdX1YvB-Azn9_dZ9fXD9ZfVTbP59HG9Wm4aSxUmTdtJSYdWKjIoThVQEApwL6Fre6OAtcoYY7kYAEvFLZKDRFZ01rKOE04JPaveH3X3czdCb0tjyXi9T650_EtH4_S_meC2-jbeaYwUY5KzovDuXiHFHzPkSY8u27IREyDOWRMliEAtFbKgb_9Dd3FOocxXKEoVYUTyJ0HXg_ExeBfgCVxfXS83GrdCtaKgiyN6azxoF4ZYerTl9DA6GwMMrsSXQipUfvsw7sWxwKaYc4LhcVKM9MEfuvhD__GHPvijVLz5e0GP_IMb6G-IDrZI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2933924285</pqid></control><display><type>article</type><title>Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ergun, Sule Berk ; Kurt, Busra</creator><creatorcontrib>Ergun, Sule Berk ; Kurt, Busra</creatorcontrib><description>Xanthelasma palpebrarum (XP) is the most common type of cutaneous xanthoma, characterized by yellowish cutaneous plaques commonly located near the medial canthus of the eyelid. Although dyslipidemia significantly contributes to its development, inflammation is also believed to be another element in the pathogenesis, especially in normolipidemic patients. Recently, cell counts derived from complete blood counts have been identified as indicators of systemic inflammatory conditions and have also been under discussion concerning their relevance to ocular diseases. This study aimed to assess inflammation indices derived from complete blood cell counts (CBC) in XP patients with normal lipid levels. Patients who had been referred to the oculoplasty department with the diagnosis of XP between January 2020 and January 2023 and age-matched control subjects were retrospectively reviewed. Patients who had abnormal lipid profiles and systemic diseases such as diabetes mellitus, hypertension, malignancy, cardiovascular diseases, systemic infections, and inflammatory diseases were not included in the study. CBC parameters were analyzed and compared between the groups. The study comprised 27 normolipidemic patients with XP and 27 age-matched healthy individuals as the control group. There were no statistically significant differences between the two groups in terms of age (p=0.143). The mean hemoglobin, neutrophil, monocyte, lymphocyte, platelet, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, and aggregate index of systemic inflammation values were higher in the patient group, but the differences were not statistically significant (p&gt;0.05). The mean red cell distribution width and platelet-to-lymphocyte ratio appeared to be lower in the patient group compared to the control group; however, no significant differences were observed between the two groups (p=0.272, p=0.387, respectively). This study might offer insights into the pathogenesis of XP, yet numerous questions remain unanswered, awaiting further investigation in future studies.</description><identifier>ISSN: 2459-1777</identifier><identifier>EISSN: 2587-0394</identifier><identifier>DOI: 10.14744/bej.2024.48802</identifier><identifier>PMID: 38504961</identifier><language>eng</language><publisher>Turkey: KARE Publishing</publisher><subject>Age ; Analysis ; Blood ; Blood platelets ; Care and treatment ; Diabetes ; Eye diseases ; Hemoglobin ; Hypertension ; Inflammation ; Inflammatory diseases ; Lipids ; Lymphocytes ; Medical examination ; Medical research ; Medicine, Experimental ; Metabolic disorders ; Neutrophils ; Original ; Pathogenesis ; Patients ; Systemic diseases ; Tıp</subject><ispartof>Beyoglu Eye Journal, 2024, Vol.9 (1), p.33-37</ispartof><rights>Copyright: © 2024 by Beyoglu Eye Training and Research Hospital.</rights><rights>COPYRIGHT 2024 KARE Publishing</rights><rights>2024. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2024 by Beyoglu Eye Training and Research Hospital 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944854/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944854/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38504961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ergun, Sule Berk</creatorcontrib><creatorcontrib>Kurt, Busra</creatorcontrib><title>Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum</title><title>Beyoglu Eye Journal</title><addtitle>Beyoglu Eye J</addtitle><description>Xanthelasma palpebrarum (XP) is the most common type of cutaneous xanthoma, characterized by yellowish cutaneous plaques commonly located near the medial canthus of the eyelid. Although dyslipidemia significantly contributes to its development, inflammation is also believed to be another element in the pathogenesis, especially in normolipidemic patients. Recently, cell counts derived from complete blood counts have been identified as indicators of systemic inflammatory conditions and have also been under discussion concerning their relevance to ocular diseases. This study aimed to assess inflammation indices derived from complete blood cell counts (CBC) in XP patients with normal lipid levels. Patients who had been referred to the oculoplasty department with the diagnosis of XP between January 2020 and January 2023 and age-matched control subjects were retrospectively reviewed. Patients who had abnormal lipid profiles and systemic diseases such as diabetes mellitus, hypertension, malignancy, cardiovascular diseases, systemic infections, and inflammatory diseases were not included in the study. CBC parameters were analyzed and compared between the groups. The study comprised 27 normolipidemic patients with XP and 27 age-matched healthy individuals as the control group. There were no statistically significant differences between the two groups in terms of age (p=0.143). The mean hemoglobin, neutrophil, monocyte, lymphocyte, platelet, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, and aggregate index of systemic inflammation values were higher in the patient group, but the differences were not statistically significant (p&gt;0.05). The mean red cell distribution width and platelet-to-lymphocyte ratio appeared to be lower in the patient group compared to the control group; however, no significant differences were observed between the two groups (p=0.272, p=0.387, respectively). This study might offer insights into the pathogenesis of XP, yet numerous questions remain unanswered, awaiting further investigation in future studies.</description><subject>Age</subject><subject>Analysis</subject><subject>Blood</subject><subject>Blood platelets</subject><subject>Care and treatment</subject><subject>Diabetes</subject><subject>Eye diseases</subject><subject>Hemoglobin</subject><subject>Hypertension</subject><subject>Inflammation</subject><subject>Inflammatory diseases</subject><subject>Lipids</subject><subject>Lymphocytes</subject><subject>Medical examination</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metabolic disorders</subject><subject>Neutrophils</subject><subject>Original</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Systemic diseases</subject><subject>Tıp</subject><issn>2459-1777</issn><issn>2587-0394</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkk1v1DAQhiMEolXpmRuKxIVLtv6M7RPabgtdaSU4gMTNcpxJ14tjL3ZSxL_H7PYDkA-2Zp55NTN-q-o1RgvMBGMXHewWBBG2YFIi8qw6JVyKBlHFnpc346rBQoiT6jznHUKIcEyw4i-rEyo5YqrFp1W3iuPewwT1pY-xr1fgfb2Kc5iaK0juDvp6HQZvxtFMLob60sXRpO-Qcu1C_bkEIUy5_ummbf3NhGkL3uTRlIzfQ5dMmsdX1YvB-Azn9_dZ9fXD9ZfVTbP59HG9Wm4aSxUmTdtJSYdWKjIoThVQEApwL6Fre6OAtcoYY7kYAEvFLZKDRFZ01rKOE04JPaveH3X3czdCb0tjyXi9T650_EtH4_S_meC2-jbeaYwUY5KzovDuXiHFHzPkSY8u27IREyDOWRMliEAtFbKgb_9Dd3FOocxXKEoVYUTyJ0HXg_ExeBfgCVxfXS83GrdCtaKgiyN6azxoF4ZYerTl9DA6GwMMrsSXQipUfvsw7sWxwKaYc4LhcVKM9MEfuvhD__GHPvijVLz5e0GP_IMb6G-IDrZI</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Ergun, Sule Berk</creator><creator>Kurt, Busra</creator><general>KARE Publishing</general><general>Kare Yayıncılık</general><general>Kare Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>IEBAR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2024</creationdate><title>Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum</title><author>Ergun, Sule Berk ; Kurt, Busra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3912-6b883f6892f9539e3e79e1d8eb6da9e469aaac57fe1895c08f80c7bcc4b525323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Analysis</topic><topic>Blood</topic><topic>Blood platelets</topic><topic>Care and treatment</topic><topic>Diabetes</topic><topic>Eye diseases</topic><topic>Hemoglobin</topic><topic>Hypertension</topic><topic>Inflammation</topic><topic>Inflammatory diseases</topic><topic>Lipids</topic><topic>Lymphocytes</topic><topic>Medical examination</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metabolic disorders</topic><topic>Neutrophils</topic><topic>Original</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Systemic diseases</topic><topic>Tıp</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ergun, Sule Berk</creatorcontrib><creatorcontrib>Kurt, Busra</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>Idealonline online kütüphane - Journals</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Beyoglu Eye Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ergun, Sule Berk</au><au>Kurt, Busra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum</atitle><jtitle>Beyoglu Eye Journal</jtitle><addtitle>Beyoglu Eye J</addtitle><date>2024</date><risdate>2024</risdate><volume>9</volume><issue>1</issue><spage>33</spage><epage>37</epage><pages>33-37</pages><issn>2459-1777</issn><eissn>2587-0394</eissn><abstract>Xanthelasma palpebrarum (XP) is the most common type of cutaneous xanthoma, characterized by yellowish cutaneous plaques commonly located near the medial canthus of the eyelid. Although dyslipidemia significantly contributes to its development, inflammation is also believed to be another element in the pathogenesis, especially in normolipidemic patients. Recently, cell counts derived from complete blood counts have been identified as indicators of systemic inflammatory conditions and have also been under discussion concerning their relevance to ocular diseases. This study aimed to assess inflammation indices derived from complete blood cell counts (CBC) in XP patients with normal lipid levels. Patients who had been referred to the oculoplasty department with the diagnosis of XP between January 2020 and January 2023 and age-matched control subjects were retrospectively reviewed. Patients who had abnormal lipid profiles and systemic diseases such as diabetes mellitus, hypertension, malignancy, cardiovascular diseases, systemic infections, and inflammatory diseases were not included in the study. CBC parameters were analyzed and compared between the groups. The study comprised 27 normolipidemic patients with XP and 27 age-matched healthy individuals as the control group. There were no statistically significant differences between the two groups in terms of age (p=0.143). The mean hemoglobin, neutrophil, monocyte, lymphocyte, platelet, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, and aggregate index of systemic inflammation values were higher in the patient group, but the differences were not statistically significant (p&gt;0.05). The mean red cell distribution width and platelet-to-lymphocyte ratio appeared to be lower in the patient group compared to the control group; however, no significant differences were observed between the two groups (p=0.272, p=0.387, respectively). This study might offer insights into the pathogenesis of XP, yet numerous questions remain unanswered, awaiting further investigation in future studies.</abstract><cop>Turkey</cop><pub>KARE Publishing</pub><pmid>38504961</pmid><doi>10.14744/bej.2024.48802</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2459-1777
ispartof Beyoglu Eye Journal, 2024, Vol.9 (1), p.33-37
issn 2459-1777
2587-0394
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10944854
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Age
Analysis
Blood
Blood platelets
Care and treatment
Diabetes
Eye diseases
Hemoglobin
Hypertension
Inflammation
Inflammatory diseases
Lipids
Lymphocytes
Medical examination
Medical research
Medicine, Experimental
Metabolic disorders
Neutrophils
Original
Pathogenesis
Patients
Systemic diseases
Tıp
title Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A53%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complete%20Blood%20Cell%20Count-Derived%20Inflammation%20Biomarkers%20in%20Patients%20with%20Xanthelasma%20Palpebrarum&rft.jtitle=Beyoglu%20Eye%20Journal&rft.au=Ergun,%20Sule%20Berk&rft.date=2024&rft.volume=9&rft.issue=1&rft.spage=33&rft.epage=37&rft.pages=33-37&rft.issn=2459-1777&rft.eissn=2587-0394&rft_id=info:doi/10.14744/bej.2024.48802&rft_dat=%3Cgale_pubme%3EA789048832%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2933924285&rft_id=info:pmid/38504961&rft_galeid=A789048832&rfr_iscdi=true